Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Romiplostim (Nplate) vs Teduglutide (Gattex)
An educational, source-based comparison of Romiplostim (Nplate) and Teduglutide (Gattex) — how each peptide works, what it's researched for, and what to know before going deeper.
Thrombopoietin-receptor peptibody for immune thrombocytopenia.
Peptibody (Fc-peptide fusion) containing TPO receptor-binding peptide domains that activate c-Mpl on megakaryocytes, stimulating platelet production without competing with endogenous TPO.
- Chronic immune thrombocytopenia (ITP)
- Pediatric ITP
- Hematopoietic syndrome of acute radiation
- • FDA-approved.
- • Reticulin fiber deposition in bone marrow; thrombosis risk with over-correction.
GLP-2 analog for short bowel syndrome dependent on parenteral support.
Recombinant analog of glucagon-like peptide-2 with alanine→glycine substitution at position 2, resisting DPP-IV degradation; promotes intestinal mucosal growth, villus height, and absorptive capacity.
- Short bowel syndrome with intestinal failure
- Reduction of parenteral nutrition dependence
- • FDA-approved.
- • Colorectal polyp surveillance required.
- • Risk of intestinal obstruction and biliary/pancreatic disease.
Romiplostim (Nplate) vs Teduglutide (Gattex) — Key differences
- Class: Romiplostim (Nplate) is classified as TPO Mimetic · Hematology, while Teduglutide (Gattex) is GLP-2 Analog · Gastrointestinal.
- Primary research focus: Romiplostim (Nplate) — chronic immune thrombocytopenia (itp); Teduglutide (Gattex) — short bowel syndrome with intestinal failure.
- Tag: FDA-Approved · Hematology vs FDA-Approved · GI.